VOYA Investment Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.3M | Buy |
417,423
+334,952
| +406% | +$17.9M | 0.02% | 504 |
|
|
2025
Q1 | $3.34M | Buy |
82,471
+62,000
| +303% | +$2.51M | ﹤0.01% | 1109 |
|
|
2024
Q4 | $570K | Sell |
20,471
-1,560
| -7% | -$43.4K | ﹤0.01% | 1883 |
|
|
2024
Q3 | $632K | Sell |
22,031
-573
| -3% | -$16.4K | ﹤0.01% | 1879 |
|
|
2024
Q2 | $530K | Buy |
22,604
+2,911
| +15% | +$68.3K | ﹤0.01% | 1967 |
|
|
2024
Q1 | $497K | Sell |
19,693
-613
| -3% | -$15.5K | ﹤0.01% | 2021 |
|
|
2023
Q4 | $474K | Sell |
20,306
-13,305
| -40% | -$311K | ﹤0.01% | 2109 |
|
|
2023
Q3 | $1.7M | Buy |
33,611
+2,553
| +8% | +$129K | ﹤0.01% | 1396 |
|
|
2023
Q2 | $1.45M | Buy |
31,058
+4,653
| +18% | +$217K | ﹤0.01% | 1483 |
|
|
2023
Q1 | $1.01M | Sell |
26,405
-10,360
| -28% | -$396K | ﹤0.01% | 1653 |
|
|
2022
Q4 | $2.01M | Buy |
36,765
+25,818
| +236% | +$1.41M | ﹤0.01% | 1328 |
|
|
2022
Q3 | $373K | Hold |
10,947
| – | – | ﹤0.01% | 2215 |
|
|
2022
Q2 | $103K | Buy |
10,947
+784
| +8% | +$7.38K | ﹤0.01% | 2608 |
|
|
2022
Q1 | $144K | Hold |
10,163
| – | – | ﹤0.01% | 2440 |
|
|
2021
Q4 | $215K | Buy |
10,163
+96
| +1% | +$2.03K | ﹤0.01% | 2471 |
|
|
2021
Q3 | $225K | Hold |
10,067
| – | – | ﹤0.01% | 2497 |
|
|
2021
Q2 | $250K | Buy |
+10,067
| New | +$250K | ﹤0.01% | 2469 |
|